Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (211-220 of 420) with videos related to

Pageof 42
Sort By:
Antimicrobial Agents and Chemotherapy|December 22, 2017
Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015Mariana Castanheira, Leonard R Duncan, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|October 22, 2005
Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion testsRonald N Jones, Thomas R Fritsche, Yigong Ge, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2026
In vitro activity of ceftobiprole against Gram-positive clinical bacterial isolates causing skin and skin structure infections in the United StatesJoshua M Maher, Rodrigo E Mendes, Mark Jones, et al.
Open Forum Infectious Diseases|March 2, 2023
Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical CentersHelio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2019
<i>In Vitro</i> Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018Robert K Flamm, Dee Shortridge, Mariana Castanheira, et al.
International Journal of Antimicrobial Agents|May 18, 2020
Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC valuesMariana Castanheira, Timothy B Doyle, Cory Hubler, et al.
International Journal of Antimicrobial Agents|December 4, 2022
In Vitro Selection of Enterobacter cloacae with Cefepime, Meropenem, and Ceftazidime-Avibactam Generates Diverse Resistance MechanismsMariana Castanheira, Jill Lindley, Timothy B Doyle, et al.
International Journal of Antimicrobial Agents|October 26, 2007
Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infectionsHelio S Sader, Rajiv Mallick, Andreas Kuznik, et al.
Diagnostic Microbiology and Infectious Disease|January 16, 2019
Antimicrobial activity of ceftolozane-tazobactam tested against gram-negative contemporary (2015-2017) isolates from hospitalized patients with pneumonia in US medical centersCecilia G Carvalhaes, Mariana Castanheira, Helio S Sader, et al.
Open Forum Infectious Diseases|February 13, 2023
Trends of β-Lactamase Occurrence Among <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase TypeMariana Castanheira, John H Kimbrough, Sean DeVries, et al.
Pageof 42

Showing results (211-220 of 420) with videos related to

Sort By:
Pageof 42
Antimicrobial Agents and Chemotherapy|December 22, 2017
Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015Mariana Castanheira, Leonard R Duncan, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|October 22, 2005
Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion testsRonald N Jones, Thomas R Fritsche, Yigong Ge, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2026
In vitro activity of ceftobiprole against Gram-positive clinical bacterial isolates causing skin and skin structure infections in the United StatesJoshua M Maher, Rodrigo E Mendes, Mark Jones, et al.
Open Forum Infectious Diseases|March 2, 2023
Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical CentersHelio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2019
<i>In Vitro</i> Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018Robert K Flamm, Dee Shortridge, Mariana Castanheira, et al.
International Journal of Antimicrobial Agents|May 18, 2020
Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC valuesMariana Castanheira, Timothy B Doyle, Cory Hubler, et al.
International Journal of Antimicrobial Agents|December 4, 2022
In Vitro Selection of Enterobacter cloacae with Cefepime, Meropenem, and Ceftazidime-Avibactam Generates Diverse Resistance MechanismsMariana Castanheira, Jill Lindley, Timothy B Doyle, et al.
International Journal of Antimicrobial Agents|October 26, 2007
Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infectionsHelio S Sader, Rajiv Mallick, Andreas Kuznik, et al.
Diagnostic Microbiology and Infectious Disease|January 16, 2019
Antimicrobial activity of ceftolozane-tazobactam tested against gram-negative contemporary (2015-2017) isolates from hospitalized patients with pneumonia in US medical centersCecilia G Carvalhaes, Mariana Castanheira, Helio S Sader, et al.
Open Forum Infectious Diseases|February 13, 2023
Trends of β-Lactamase Occurrence Among <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase TypeMariana Castanheira, John H Kimbrough, Sean DeVries, et al.
Pageof 42